CAS 71539-52-1

Oxycodone N-Oxide

Produit contrôlé

CAS : 71539-52-1

Formule : C₁₈H₂₁NO₅

Couleur et forme : Neat

Masse moléculaire : 331.36

Ref: 86-MM0672.06

Oxycodone N-Oxide (1.0mg/ml in Methanol)

Produit contrôlé

CAS : 71539-52-1

Formule : C₁₈H₂₁NO₅

Couleur et forme : Colourless

Masse moléculaire : 331.36

Ref: TR-KIT2385

Oxycodone N-Oxide

Produit contrôlé

CAS : 71539-52-1

Applications Oxycodone N-Oxide is a metabolite of Oxycodone (O870600), a semisynthetic codeine derivative that has been used both as an analgesic and antitussive.
References Moore, K.A. et al.: J. Anal. Toxicol., 27, 346 (2003); Ishida, T. et al.: J. Pharmacobio-Dyn., 5, 521 (1982); Ishida, T. et al.: Drug Metab. Dispos., 7, 162 (1979);

Formule : C₁₈H₂₁NO₅

Couleur et forme : White To Light Yellow

Masse moléculaire : 331.36

Ref: TR-O870610

Oxycodone-d3 N-Oxide

Produit contrôlé

CAS : 71539-52-1

Applications Labelled analogue of Oxycodone N-Oxide, a metabolite of Oxycodone (O870600), a semisynthetic codeine derivative that has been used both as an analgesic and antitussive.
References Moore, K.A. et al.: J. Anal. Toxicol., 27, 346 (2003); Ishida, T. et al.: J. Pharmacobio-Dyn., 5, 521 (1982); Ishida, T. et al.: Drug Metab. Dispos., 7, 162 (1979);

Formule : C₁₈D₃H₁₈NO₅

Couleur et forme : Neat

Masse moléculaire : 334.382

Ref: TR-O870612

Oxycodone N-oxide

Produit contrôlé

CAS : 71539-52-1

Oxycodone is an opioid drug that has been used in the treatment of severe pain, cough suppression, and as a preoperative medication. It is available as a single agent or in combination preparations with acetaminophen or ibuprofen. Oxycodone binds to opioid receptors in the central nervous system and increases dopamine levels in the brain. It also inhibits the release of norepinephrine from sympathetic nerve terminals, which may explain its anti-inflammatory effects. Oxycodone can cause dizziness, nausea, vomiting, constipation, and dry mouth when taken at high doses. This drug can interact with other drugs such as nonsteroidal anti-inflammatory drugs (NSAIDs), which will increase the risk for gastrointestinal bleeding and heart attacks. The adverse effects of oxycodone may be reduced by a two-way crossover design study that includes microdialysis probes and multivariate logistic regression analysis.

Formule : C₁₈H₂₁NO₅

Degré de pureté : Min. 95%

Masse moléculaire : 331.4 g/mol

Ref: 3D-WCA53952

Oxycodone Related Compound B CII (oxycodone N-oxide)

Produit contrôlé

CAS : 71539-52-1

Alkaloids of opium and their derivatives, salts thereof, not elsewhere specified or included

Formule : C₁₈H₂₁NO₅

Couleur et forme : Off-White Tan Powder

Masse moléculaire : 331.14197

Ref: 45-1485227